JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M308337200 on October 7, 2003

J. Biol. Chem., Vol. 279, Issue 1, 77-85, January 2, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/1/77    most recent
M308337200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taimi, M.
Right arrow Articles by Petkovich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taimi, M.
Right arrow Articles by Petkovich, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid*

Mohammed Taimi{ddagger}, Christian Helvig{ddagger}, Jan Wisniewski{ddagger}, Heather Ramshaw{ddagger}, Jay White{ddagger}, Ma'an Amad{ddagger}, Bozena Korczak{ddagger}§, and Martin Petkovich¶||

From the {ddagger}Cytochroma Inc., Markham, Ontario L3R 8E4 and Cancer Research Laboratories, Queen's University, Kingston, Ontario K7L 3N6, Canada

Retinoids are potent regulators of cell proliferation, cell differentiation, and morphogenesis and are important therapeutic agents in oncology and dermatology. The gene regulatory activity of endogenous retinoids is effected primarily by retinoic acid isomers (all-trans and 9-cis) that are synthesized from retinaldehyde precursors in a broad range of tissues and act as ligands for nuclear retinoic acid receptors. The catabolism of all-trans-retinoic acid (atRA) is an important mechanism of controlling RA levels in cell and tissues. We have previously identified two cytochrome P450s, P450RAI-1 and P450RAI-2 (herein named CYP26A1 and CYP26B1), which were shown to be responsible for catabolism of atRA both in the embryo and the adult. In this report, we describe the identification, molecular cloning, and substrate characterization of a third member of the CYP26 family, named CYP26C1. Transiently transfected cells expressing CYP26C1 convert atRA to polar water-soluble metabolites similar to those generated by CYP26A1 and -B1. Competition studies with all-trans, 13-cis, and 9-cis isomers of retinoic acid demonstrated that atRA was the preferred substrate for CYP26C1. Although CYP26C1 shares extensive sequence similarity with CYP26A1 and CYP26B1, its catalytic activity appears distinct from those of other CYP26 family members. Specifically, CYP26C1 can also recognize and metabolize 9-cis-RA and is much less sensitive than the other CYP26 family members to the inhibitory effects of ketoconazole. CYP26C1 is not widely expressed in the adult but is inducible by RA in HPK1a, transformed human keratinocyte cell lines. This third CYP26 member may play a specific role in catabolizing both all-trans and 9-cis isomers of RA.


Received for publication, July 30, 2003 , and in revised form, October 6, 2003.

* This work was supported in part by Cytochroma Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| Supported by the National Cancer Institute of Canada, Canadian Institute of Health Research and Cytochroma Inc.

§ To whom correspondence should be addressed: Cytochroma Inc., 330 Cochrane Drive, Markham, Ontario L3R 8E4, Canada. Tel.: 905-479-5306 (ext. 326); Fax: 905-479-1287; E-mail: bozena{at}cytochroma.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y.-K. Kim, L. Wassef, L. Hamberger, R. Piantedosi, K. Palczewski, W. S. Blaner, and L. Quadro
Retinyl Ester Formation by Lecithin:Retinol Acyltransferase Is a Key Regulator of Retinoid Homeostasis in Mouse Embryogenesis
J. Biol. Chem., February 29, 2008; 283(9): 5611 - 5621.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
J. R. Muindi, M. D. Roth, R. A. Wise, J. E. Connett, G. T. O'Connor, J. W. Ramsdell, N. W. Schluger, M. Romkes, R. A. Branch, F. C. Sciurba, et al.
Pharmacokinetics and Metabolism of All-trans- and 13-cis-Retinoic Acid in Pulmonary Emphysema Patients
J. Clin. Pharmacol., January 1, 2008; 48(1): 96 - 107.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo
CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1542 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
O. Oppenheimer, N.-K. Cheung, and W. L. Gerald
The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma
Mol. Cancer Ther., April 1, 2007; 6(4): 1300 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Zolfaghari, C. J. Cifelli, S. O. Lieu, Q. Chen, N.-q. Li, and A. C. Ross
Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo
Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1029 - G1036.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. E. Hernandez, A. P. Putzke, J. P. Myers, L. Margaretha, and C. B. Moens
Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development
Development, January 1, 2007; 134(1): 177 - 187.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Osanai, N. Nishikiori, M. Murata, H. Chiba, T. Kojima, and N. Sawada
Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor {alpha} Agonists in Colitis
Mol. Pharmacol., January 1, 2007; 71(1): 250 - 258.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Roberts, S. Ivins, A. C. Cook, A. Baldini, and P. J. Scambler
Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick
Hum. Mol. Genet., December 1, 2006; 15(23): 3394 - 3410.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Gu, F. Xu, W. Song, X. Wang, P. Hu, Y. Yang, X. Gao, and Q. Zhao
A Novel Cytochrome P450, Zebrafish Cyp26D1, Is Involved in Metabolism of All-trans Retinoic Acid
Mol. Endocrinol., July 1, 2006; 20(7): 1661 - 1672.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
B Dlugaszewska, A Silahtaroglu, C Menzel, S Kubart, M Cohen, S Mundlos, Z Tumer, K Kjaer, U Friedrich, H-H Ropers, et al.
Breakpoints around the HOXD cluster result in various limb malformations
J. Med. Genet., February 1, 2006; 43(2): 111 - 118.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Vernet, C. Dennefeld, C. Rochette-Egly, M. Oulad-Abdelghani, P. Chambon, N. B. Ghyselinck, and M. Mark
Retinoic Acid Metabolism and Signaling Pathways in the Adult and Developing Mouse Testis
Endocrinology, January 1, 2006; 147(1): 96 - 110.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. Sen, S. Harpavat, M. A. Peters, and C. L. Cepko
Retinoic acid regulates the expression of dorsoventral topographic guidance molecules in the chick retina
Development, December 1, 2005; 132(23): 5147 - 5159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Moise, V. Kuksa, W. S. Blaner, W. Baehr, and K. Palczewski
Metabolism and Transactivation Activity of 13,14-Dihydroretinoic Acid
J. Biol. Chem., July 29, 2005; 280(30): 27815 - 27825.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Osanai and M. Petkovich
Expression of the Retinoic Acid-Metabolizing Enzyme CYP26A1 Limits Programmed Cell Death
Mol. Pharmacol., May 1, 2005; 67(5): 1808 - 1817.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Moise, V. Kuksa, Y. Imanishi, and K. Palczewski
Identification of All-trans-Retinol:All-trans-13,14-dihydroretinol Saturase
J. Biol. Chem., November 26, 2004; 279(48): 50230 - 50242.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. G. Villani, V. Appierto, E. Cavadini, M. Valsecchi, S. Sonnino, R. W. Curley, and F. Formelli
Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1
Clin. Cancer Res., September 15, 2004; 10(18): 6265 - 6275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.